SCHEMBL28837954

SCHEMBL28837954

C=C(C)c1cccc2c(C)c(C)n(C(N)=O)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FABP4 P15090 1/20 0.41
▸ EDNRA P25101 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MYC P01106 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ALDH1A1 P00352 5/20 0.32
▸ MAPT P10636 3/20 0.32
▸ POLB P06746 1/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ CYP2C19 P33261 2/20 0.31
▸ NR1I2 O75469 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ CNR2 P34972 1/20 0.31
▸ NR1H4 Q96RI1 1/20 0.31
▸ CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28164948 0.69 FABP4 (0.48) FABP4MEN1KMT2AMYCLMNA
Hydrochloric Acid SCHEMBL28531727 0.68 MAPT (0.49) MEN1KMT2ALMNATDP1ALDH1A1
SCHEMBL28499183 0.68 LMNA (0.43) MEN1KMT2ALMNATDP1ALDH1A1
SCHEMBL28837916 0.68 MAOA (0.38) FABP4MEN1KMT2ALMNATDP1
Hydrochloric Acid SCHEMBL28263901 0.68 FABP4 (0.43) FABP4MEN1KMT2AMYCLMNA
SCHEMBL28164552 0.68 FABP4 (0.43) FABP4MEN1KMT2AMYCLMNA
SCHEMBL28164438 0.68 FABP4 (0.43) FABP4MEN1KMT2AMYCLMNA
SCHEMBL28165039 0.66 FABP4 (0.62) FABP4MEN1KMT2AMYCLMNA
SCHEMBL3113613 0.65 MAPT (0.32) FABP4MEN1KMT2AALDH1A1MAPT
Formamide SCHEMBL4205324 0.65 MAPT (0.46) MEN1KMT2ALMNATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115028617-A Heterocyclic inhibitors of CBP/EP300 and their use in the treatment of cancer 基因泰克公司 2022-09-09 — — CN disclosed
CN-109476641-B Heterocyclic inhibitors of CBP/EP300 and their use in the treatment of cancer 基因泰克公司 2022-07-05 — — CN disclosed
Send feedback